Tattoo Ink Safety: FDA Rules, MoCRA, Recalls & How to Read a Label

THE MAIN REGULATORY DISTINCTION

Is Any Tattoo Ink Approved by the FDA?

The U.S. Food and Drug Administration considers inks used for intradermal tattooing, including permanent makeup, to be cosmetics. Pigments used to make those colors are classified as color additives under federal law.

Color additives are subject to FDA premarket-approval requirements for their intended uses. However, the FDA states that no color additives are approved for injection into the skin, whether for a conventional tattoo or permanent makeup. The agency also explains that using an unapproved color additive in tattoo ink makes the ink adulterated under the Federal Food, Drug, and Cosmetic Act.

That distinction matters when reading product listings and advertising. A manufacturer may have filed a cosmetic facility registration or submitted a cosmetic product listing. Those activities are not the same as FDA approval of a tattoo pigment for injection.

In a September 9, 2026 announcement, the FDA clarified that it does not issue certificates or other documents to verify compliance for cosmetic facility registration or product listing. Registration information should therefore be interpreted as an administrative regulatory record, not as a product-approval certificate.

FDA authority also differs from the inspection and licensing of a tattoo establishment. The agency monitors cosmetic products, including ink, while local or state jurisdictions establish requirements for how tattoo procedures are performed and how studios operate.

DIFFERENT AUTHORITIES, DIFFERENT RESPONSIBILITIES

Who Regulates Tattoo Ink and Tattoo Studios?

Tattoo ink production and the actual act of tattooing are related but distinct activities. The FDA's tattoo fact sheet explains that the federal government oversees the inks as cosmetic products, while the practice of tattooing is primarily regulated locally.

For an artist or studio owner, the practical approach is to maintain two lines of information: the current requirements of the body-art authority overseeing the establishment and the federal product information relevant to the ink being purchased.

An ink's label and the manufacturer's documentation support product identification. The studio's own client records support traceability after the bottle has been opened and portions of ink have been used in individual procedures.

THE MODERNIZATION OF COSMETICS REGULATION ACT

What Changed Under MoCRA for Tattoo Ink Manufacturers?

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) expanded the FDA's authority over cosmetic products and added requirements for manufacturers, processors and the responsible persons whose names appear on product labels.

Because tattoo and PMU inks are cosmetics under FDA rules, those federal provisions are relevant to the ink industry. MoCRA concerns manufacturer and responsible-person obligations; it does not create an FDA approval for injecting tattoo colors into skin.

Under MoCRA, serious adverse events include outcomes specifically defined in the law, such as infection, hospitalization, a life-threatening experience and significant disfigurement. The responsible person has a reporting deadline of 15 business days after receiving a qualifying report and must submit the required label copy.

The law also addresses new and material medical information received within a year of the original report. When that information must be submitted, the same 15-business-day reporting deadline applies after receipt.

The adverse-event contact requirement is separate from the ordinary business name and address already required on cosmetic labeling. Section 609(a), codified at 21 U.S.C. 364e(a), took effect on December 29, 2024. It calls for a domestic address, domestic telephone number or electronic contact through which the responsible person can receive reports.

MoCRA also provides a process for a mandatory cosmetic recall when the statutory risk conditions are met and a responsible person does not voluntarily stop distribution and recall the affected product. In October 2026, the FDA issued final guidance explaining that authority.

A manufacturer registration, a product listing and an adverse-event submission serve different legal functions. None is a certificate that the tattoo ink has been approved for injection.

READ THE ENTIRE BOTTLE

How to Read a Tattoo Ink Label, Line by Line

A tattoo ink bottle combines product identity, quantity and company information with markings used for manufacturing and traceability. The FDA's cosmetics labeling guide establishes general labeling requirements, while many ink manufacturers print additional information for identifying specific batches and products.

When reviewing a new bottle, distinguish federal labeling information from manufacturer-added identifiers. Both can be useful to the artist, but they are not all imposed by the same rule.

The FDA's May 7, 2025 tattoo ink advisory provides a real example of how several markings can appear together on a product. The agency reproduced these identifying details:

A lot code can be especially important because an official notice may identify only particular batches or dates. Search using the exact characters printed on the bottle, including any letters or numbers that distinguish one lot from another.

The FDA requests lot or batch information when a product-related reaction is reported. The American Academy of Dermatology (AAD) also recommends that tattoo artists record the ink color, manufacturer and lot number for each tattoo.

When purchasing from a supplier, keep enough documentation to connect the bottle, label and order record. That makes it easier to trace a specific product after the label is no longer immediately accessible at the workstation.

A LABELING DISTINCTION THAT MATTERS

Must Every Tattoo Ink Bottle List All Ingredients?

The FDA's cosmetic labeling guidance distinguishes products distributed for retail sale to consumers for personal use from products that are not customarily distributed at retail and are used by professionals in their establishments.

Under 21 CFR 701.3, cosmetics produced or distributed for retail consumer use generally require an ingredient declaration. The FDA describes an exemption for certain products not customarily distributed for retail sale and used by professionals at their workplaces, provided those products are not also sold to consumers for personal use.

This means an artist should review the product's actual distribution and labeling context rather than assuming a single ingredient-list rule applies identically to every professional bottle. When ingredient declarations are required, the FDA generally calls for ingredients to appear in descending order of predominance, subject to specified exceptions.

MoCRA product listing is a separate obligation. The responsible person's FDA listing must include the product's ingredients, including relevant colors, fragrances or flavors, and must be updated annually as required.

The artist can also request available manufacturer documentation, such as an SDS (Safety Data Sheet), to review product identification, handling and storage information. An SDS serves a different purpose from the bottle's retail ingredient declaration or MoCRA product listing.

When selecting a new ink or diluent, use the current label and appropriate product documentation together. Keep the shade, bottle size and batch information attached to the inventory entry.

INTERPRETING A PRODUCT CLAIM

What Does "Sterile" on a Tattoo Ink Bottle Mean?

A manufacturer may use the word sterile to describe the microbiological condition of an ink after its processing. That is a statement about the product as supplied and the manufacturer's relevant production and handling procedures.

The FDA cautions that tattoo ink may contain microorganisms even when a container is unopened, sealed or labeled sterile. This matters because tattoo ink is introduced into skin rather than simply applied to its surface.

The agency's concern includes possible contamination with bacteria, mold and other microorganisms. It also notes that infections from contaminated ink have occurred even when tattoo artists followed hygienic procedures.

An artist comparing tattoo inks can therefore review the manufacturer's processing descriptions, label condition, lot information, storage directions and available documentation together. The appearance of a closed bottle is not a microbiological test.

A clearly printed lot number helps the studio identify the batch if a manufacturer or regulator later publishes a specific notice. The same traceability principle applies to any diluent used during the session.

WHERE A PRODUCT ISSUE CAN BEGIN

How Can Tattoo Ink Become Contaminated?

The FDA describes microbial contamination as a concern throughout the preparation, packing, holding and handling of tattoo inks. Potential organisms include bacteria, mold and other microorganisms that can enter the product before it reaches an artist.

One manufacturing-related pathway is contaminated ingredients or equipment. Another is a process that introduces microorganisms while pigment and liquid components are combined, filled into containers or held before distribution.

The FDA specifically identifies dilution using non-sterile water as a common source of contamination. Adding ordinary tap water to tattoo ink is therefore inconsistent with the agency's warnings about dilution practices.

A diluent is a separate product in the artist's working system. Record its identity and lot where applicable, just as the FDA recommends recording information about the ink itself after a suspected product-related reaction.

On October 24, 2024, the FDA issued final guidance titled Insanitary Conditions in the Preparation, Packing, and Holding of Tattoo Inks and the Risk of Microbial Contamination. It recommends measures such as testing ink and ink components for possible microbial contamination and ensuring appropriate sterilization methods are used, when applicable.

That FDA guidance addresses manufacturer and distributor practices. At the studio level, artists still need a defined procedure for handling bottles, preparing ink portions and recording the products used for each client.

UNDERSTANDING FDA ACTIONS OVER TIME

Tattoo Ink Recalls, FDA Warnings and the 2024 Guidance

An FDA safety alert, a company's voluntary recall, a warning letter and a mandatory recall are distinct regulatory actions or communications. Reading the notice type helps an artist understand whether a specific product is being recalled, whether the agency is issuing an alert or whether the FDA is discussing a wider manufacturing concern.

In its October 2024 announcement, the FDA reported that 18 voluntary tattoo ink recalls took place between 2003 and 2024 involving microbial contamination. That figure describes the historical period reviewed in the agency's announcement.

For an artist or retailer, the important next question is whether a notice identifies a particular ink, color, lot or date range that matches current stock. The existence of a warning or historical recall is not enough to identify the exact bottle without reviewing those details.

TWO OFFICIAL EXAMPLES OF PRODUCT IDENTIFICATION

FDA Tattoo Ink Notices from 2024 and 2025

These public examples show how the FDA identifies affected tattoo inks through company announcements, specific product names and lot codes. They also show why a studio should compare the full notice against its product records.

Both examples are useful for learning how product-specific notices are written. A studio should rely on the current status and instructions in the original FDA notice and any linked updates when examining its inventory.

LOOK UP A SPECIFIC BOTTLE

How to Check Whether a Tattoo Ink Has Been Recalled

The FDA provides more than one public recall resource. For an accurate inventory check, use the public safety-alert listings, the more comprehensive Enforcement Report and the FDA's tattoo and permanent makeup information pages.

1. Write down the bottle identity.

   Collect the exact brand, product or color name, bottle size, lot or batch number and relevant manufacturing or best-before dates. Check the original packaging or purchase record when useful.

2. Search the FDA Recalls, Market Withdrawals & Safety Alerts page.

   Enter the ink name or company and use the Cosmetics product-type filter. Open any relevant notice and read the product descriptions and affected lot information.

3. Search the FDA Enforcement Report.

   Use Advanced Search to narrow by product description, recalling firm, product type, recall class or status. The record may contain more detailed batch and recall information.

4. Include records pending classification.

   The Enforcement Report can show entries labeled Not Yet Classified before the FDA completes its risk classification. Review those entries when checking recent products.

5. Compare the notice against the physical bottle.

   Confirm product name, color, packaging, lot or batch code and applicable dates. A similar brand name or shade alone is not an exact lot match.

6. Read the agency's instructions and linked updates.

   Review the original notice, current status and any instructions issued for the affected product. Keep the relevant notice connected to the studio's product record.

The FDA explains that not every recall receives a press release or appears on the public alerts page. That is why the Enforcement Report is important. The agency says it includes recalls monitored by the FDA once classified, with some entries appearing earlier as Not Yet Classified.

What Do Recall Class I, II and III Mean?

The FDA classifies recalls to communicate the relative degree of health hazard associated with a particular product issue.

The most useful inventory comparison is product + color + lot + dates. An FDA recall classification describes a particular recall; it does not replace reading the affected product and code information.

TRACEABILITY IN A REAL STUDIO

What Tattoo Ink Information Should Be Recorded for Each Client?

Ink traceability begins before a bottle is emptied. The AAD recommends that tattoo artists record the color, manufacturer and lot number of each pigment used for a tattoo. The FDA requests the same core information when an ink-related reaction is reported.

The record should be specific enough to identify the actual product, especially when a session uses several colors or a separate diluent. A note that says only "black" or "red" provides less detail than the product name, shade and batch.

The FDA's consumer guidance specifically asks for the ink or diluent's brand, color and lot or batch number to help investigate a reported problem. An artist can use that same set of fields in the studio's client record.

A practical approach is to record the code when the ink is poured, while the container is still at the workstation. Keep the source information available for future inventory checks, reporting or supplier correspondence.

If an agency notice is issued, the studio can compare its stock records and client-use history with the affected lot information rather than relying on memory.

RECOGNIZE WHEN TO SEEK PROFESSIONAL HELP

What Does the FDA Say About a Possible Tattoo Ink Reaction?

The FDA advises people to contact a healthcare professional when they suspect an infection or another reaction related to a tattoo. Its consumer guidance mentions an area that does not seem to be healing or a rash, redness or bumps near the tattoo, especially with a fever.

The agency's product notices also describe infections associated with contaminated ink that may produce red papules or other lesions in areas where a particular ink was applied. Skin reactions can have different causes, so a medical professional should evaluate a concerning condition.

The FDA advises notifying the tattoo artist so they can identify the ink and avoid using it again, and asking for the brand, color and any lot or batch number of the ink or diluent.

Reporting an unexpected reaction is useful even when its cause has not yet been established. The FDA uses information from consumers, artists and healthcare professionals to monitor possible cosmetic product problems.

OFFICIAL FDA REPORTING CHANNELS

How to Report a Tattoo Ink Reaction to the FDA

The FDA accepts cosmetic product complaints and adverse-event reports from consumers, tattoo artists and healthcare professionals. Its reporting page specifically includes tattoo ink and permanent makeup among the cosmetic products covered.

The agency recommends providing as much useful detail as possible about the product, reaction and outcome. The report can describe what happened and include the information identifying the ink or diluent involved.

1. Contact a healthcare professional about the reaction.

   The FDA advises seeking professional healthcare guidance for a suspected infection or other concerning reaction.

2. Identify the ink or diluent.

   Record the manufacturer, product and color name, lot or batch code, and relevant container dates.

3. Write down the event details.

   Include when the tattoo or PMU procedure occurred, when symptoms appeared and any relevant outcome information.

4. Submit a report through the FDA.

   Consumers and healthcare professionals can use the online MedWatch voluntary reporting form or the FDA's Food and Cosmetics Information Center telephone service.

5. Retain the product information.

   Keep the relevant label and supplier documentation available in case the FDA requests additional details.

MoCRA's mandatory 15-business-day reporting rule concerns the responsible person and qualifying serious adverse events. An individual consumer or artist using MedWatch is following the FDA's voluntary reporting route.

Reports can be useful for identifying patterns of reactions or product-quality concerns. Accurate brand, color, lot and diluent records make those reports more informative.

PERMANENT MAKEUP IS INCLUDED

Do the Same FDA Rules Apply to Permanent Makeup Pigments?

Yes. The FDA describes permanent makeup as a form of intradermal tattooing and includes PMU pigments within its regulation of tattoo inks as cosmetics.

The absence of FDA-approved color additives for injection applies to tattoo pigments used for traditional body art and permanent makeup. The FDA's cosmetic reporting system also accepts complaints involving both product categories.

MoCRA's federal cosmetics requirements are relevant to the manufacturer or responsible person for products within its scope. PMU professionals should check the exact pigment identity, applicable product information, batch markings and the local requirements governing their work.

Studio records for PMU pigments can use the same fundamental identification fields: product name, color, manufacturer and lot, with diluent information when applicable. This supports the FDA's request for specific product information if a reaction is reported.

USE THIS BEFORE ORDERING OR OPENING INK

Tattoo Ink Purchasing and Inventory Checklist

A repeatable buying check helps artists and studio managers verify that the product delivered matches the intended order and that the available records are sufficient to identify the bottle later.

This checklist centers on information that can be verified from the bottle, official regulatory resources and supplier records. It complements the studio's local body-art procedures and professional ink-handling workflow.

COMMON QUESTIONS FROM ARTISTS AND CLIENTS

Tattoo Ink FDA, MoCRA, Label and Recall FAQ

OFFICIAL U.S. REGULATORY AND DERMATOLOGY SOURCES

Sources Consulted

FDA product guidance, regulatory pages, official recall notices, the U.S. Code published by the Government Publishing Office and AAD statements were used to prepare this guide. The sources below support the federal requirements, labeling distinctions, recall search process and reaction-reporting instructions.

• FDA — Tattoos & Permanent Makeup Fact Sheet Tattoo and PMU inks as cosmetics, color additives, and federal versus local jurisdiction.
• FDA — Tattoos, Temporary Tattoos & Permanent Makeup Regulatory background, tattoo ink safety updates and public notices.
• FDA — Think Before You Ink: Tattoo Safety Microbial contamination, dilution water, sealed bottles, reaction guidance and lot identification.
• FDA — Modernization of Cosmetics Regulation Act of 2022 Registration, listing, serious adverse-event reporting, small-business exemptions and mandatory recall authority.
• FDA — Cosmetic Facility Registration & Product Listing Biennial facility renewal, product listing through Cosmetics Direct and the FDA's notice that it does not issue compliance certificates.
• U.S. Code — 21 U.S.C. 364e, Cosmetic Labeling Domestic adverse-event contact information and the December 29, 2024 effective date.
• FDA — Summary of Cosmetics Labeling Requirements Product identity, net contents, firm information, imported-country markings, ingredients and warnings.
• FDA — Cosmetics Labeling Guide Retail ingredient declarations and the professional-use labeling distinction.
• FDA — Cosmetics Direct FDA's Structured Product Labeling tool for facility registration and product listing submissions.
• FDA — Final Tattoo Ink Guidance Announcement, October 24, 2024 Historical recall count, 2019 actions and manufacturer contamination-control recommendations.
• FDA — Insanitary Conditions in Tattoo Ink Manufacturing October 2024 final guidance on microbial contamination during preparation, packing and holding.
• FDA — Sierra Stain / Bloodline Recall, August 2024 Official voluntary recall announcement and affected product-code information.
• FDA — Sacred Tattoo Ink Safety Notice, May 7, 2025 Specific colors, lot codes, color-index numbers, best-before dates and laboratory findings.
• FDA — Recalls, Market Withdrawals & Safety Alerts Public product notices and Cosmetics filtering.
• FDA — Enforcement Report Information and Definitions Advanced Search, lot-code fields, status, Classes I–III and Not Yet Classified entries.
• FDA — Cosmetic Recall Policy Voluntary recalls and MoCRA's mandatory recall authority.
• FDA — Final Guidance on Mandatory Cosmetic Recalls, October 2026 Updated FDA explanation of the mandatory recall process under MoCRA.
• FDA — How to Report a Cosmetic Product Complaint MedWatch, FCIC telephone reporting, consumer submissions and industry reporting obligations.
• American Academy of Dermatology — Permanent Makeup, June 18, 2024 Recommendation that tattoo artists record pigment color, manufacturer and lot number.

Editorial note: Updated November 13, 2026. This article explains FDA-published regulatory information, product labeling and official recall resources for professional tattoo and PMU purchasing. For product-specific notices, review the current FDA record and its exact identification details; for possible reactions, contact a healthcare professional and use the FDA reporting channels.